ImmunityBio, Inc. has grown revenue 554% a year over three years and 203% a year over five. Revenue growth, 3-year annual rate: +554% (Biotechnology median +21%). Revenue growth, 5-year rate: +203%, growth has picked up over the last three years. Years of annual history on file: 13, FY2013 to FY2025, as filed.

IBRXImmunityBio, Inc.

HealthcareUSD

$8.24

$1.9852 weeks$11.55

Is it growing?

Is IBRX growing?

ImmunityBio, Inc. has grown revenue 554% a year over three years and 203% a year over five.

+554%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +203%
Revenue growth, 5-year rate · +554% over three · growth has picked up over the last three years
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›